Edwards Lifesciences CorporationEWNYSE
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+7.3%
5Y CAGR+9.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+7.3%/yr
vs +10.1%/yr prior
5Y CAGR
+9.3%/yr
Consistent
Acceleration
-2.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.10B | +5.5% |
| 2024 | $2.94B | +15.6% |
| 2023 | $2.55B | +1.3% |
| 2022 | $2.51B | +4.9% |
| 2021 | $2.40B | +20.3% |
| 2020 | $1.99B | -0.2% |
| 2019 | $1.99B | +16.8% |
| 2018 | $1.71B | +10.8% |
| 2017 | $1.54B | +14.9% |
| 2016 | $1.34B | - |